Cargando…
Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia
The development of vaccines against severe acute respiratory syndrome coronavirus 2, which features high mortality and morbidity rates, has progressed at an unprecedented rate, and vaccines are currently in use worldwide. Thrombotic events after vaccination are accompanied by thrombocytopenia, and t...
Autor principal: | Park, Young Shil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Pediatric Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342878/ https://www.ncbi.nlm.nih.gov/pubmed/34237213 http://dx.doi.org/10.3345/cep.2021.00717 |
Ejemplares similares
-
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
por: Leung, Halina H. L., et al.
Publicado: (2022) -
Deep vein thrombosis as thrombotic sequelae of vaccine-induced thrombotic thrombocytopenia
por: Osei, Racheal, et al.
Publicado: (2023) -
Vaccine-induced immune thrombotic thrombocytopenia
por: Klok, Frederikus A, et al.
Publicado: (2022) -
Vaccine-induced immune thrombotic thrombocytopenia
por: Kanack, Adam J., et al.
Publicado: (2022) -
Vaccine-induced immune thrombotic thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2023)